Literature DB >> 17725542

ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.

Herbert Stepp1, Tobias Beck, Thomas Pongratz, Thomas Meinel, Friedrich-Wilhelm Kreth, Jörg Ch Tonn, Walter Stummer.   

Abstract

BACKGROUND: Oral application of 20 mg/kg body weight of 5-aminolevulinic acid (ALA) leads to a highly specific accumulation of fluorescent Protoporphyrin IX (PPIX) in malignant glioma tissue. In the past few years, we have participated in several clinical studies designed to investigate fluorescence guided resection (FGR) and photodynamic therapy (PDT).
METHODS: PPIX selectivity and PPIX bleaching during PDT were assessed with spectroscopic measurements. FGR was performed in 18 clinics in Germany (ALA-Glioma Study Group, participants see end of paper) in a phase III trial comprising an ALA group and a white-light group. PDT was performed with microlens fibers or cylindrical diffusers postsurgically to the resection bed. Additionally, a protocol for the interstitial stereotactic placement of cylindrical diffusers was established and applied on patients with recurrent, inoperable glioblastoma.
RESULTS: Compared to normal cortex, mean PPIX fluorescence in vital tumor was found more than 100-fold increased. During PDT, the PPIX fluorescence bleached to 8%, 16%, and 1% of the initial intensity for the 100, 150, and 200 J/cm2 groups (median values). FGR: Contrast-enhancing tumor was completely resected in 65% of patients in the ALA group compared to 36% in the white-light group (p < 0.0001). Progression-free survival was superior in the ALA group compared to white-light patients with cumulative 6 months progression-free survival rates of 41% and 21% (p = 0.0003), respectively. Interstitial PDT can be performed with multiple radial diffusers approximately 10 mm apart, 200 mW/cm, and an irradiation time of one hour.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725542     DOI: 10.1615/jenvironpatholtoxicoloncol.v26.i2.110

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  38 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Photodynamic therapy mediated by 5-aminolevulinic acid suppresses gliomas growth by decreasing the microvessels.

Authors:  Wei Yi; Hai-Tao Xu; Dao-Feng Tian; Li-Quan Wu; Shen-Qi Zhang; Long Wang; Bao-Wei Ji; Xiao-Nan Zhu; Humphrey Okechi; Gang Liu; Qian-Xue Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 3.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

Review 4.  Optical technologies for intraoperative neurosurgical guidance.

Authors:  Pablo A Valdés; David W Roberts; Fa-Ke Lu; Alexandra Golby
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

5.  Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.

Authors:  Adnan O Abu-Yousif; Anne C E Moor; Xiang Zheng; Mark D Savellano; Weiping Yu; Pål K Selbo; Tayyaba Hasan
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

6.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.

Authors:  David W Roberts; Pablo A Valdés; Brent T Harris; Kathryn M Fontaine; Alexander Hartov; Xiaoyao Fan; Songbai Ji; S Scott Lollis; Brian W Pogue; Frederic Leblond; Tor D Tosteson; Brian C Wilson; Keith D Paulsen
Journal:  J Neurosurg       Date:  2010-04-09       Impact factor: 5.115

7.  Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes.

Authors:  Michael J Hayes; Victoria Kaestner; Sham Mailankody; Vinay Prasad
Journal:  CMAJ Open       Date:  2018-01-15

8.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

9.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

10.  In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.

Authors:  Hiroyuki Kishimoto; Ming Zhao; Katsuhiro Hayashi; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara; Sheldon Penman; Robert M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.